{
  "meta": {
    "id": "test85",
    "title": "Small Molecule Inhibitors",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following has the least bone marrow suppression?",
      "options": [
        {
          "label": "A",
          "text": "Vincristine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Vinblastine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vinorelbine",
          "correct": false
        },
        {
          "label": "D",
          "text": "all of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Vincristine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Vincristine Vincristine , is an anti-cancer medication used in the treatment of breast cancer, non-small cell lung cancer, pancreatic cancer , kidney cancer, blood cancer, multiple myeloma, lymphoma, and bone cancer.</p>\n<p><strong>Highyeild:</strong></p><p>Bone marrow sparing/ minimal effect on BM cytotoxic drugs Vincristine (not vinblastine /vinorelbine) Bleomycin L-asparaginase Vincristine: very limited myelosuppressive action makes it a valuable component of several combination therapy regimens for leukemia and lymphoma neurotoxic drug</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. It is a chemotherapy medication, typically used with other medications, to treat several types of cancer. This includes Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. Option: C. It is a chemotherapy medication used to treat several types of cancer. This includes breast cancer and non-small cell lung cancer. It is given by injection into a vein or by mouth. Common side effects include bone marrow suppression.</p>\n<p><strong>Extraedge:</strong></p><p>Vincristine is delivered via intravenous infusion for use in various types of chemotherapy regimens. Its main uses are in non-Hodgkin's lymphoma as part of the chemotherapy regimen CHOP R-CVP, Hodgkin's lymphoma as part of MOPP, COPP, BEACOPP, or the less popular Stanford V chemotherapy regimen in acute lymphoblastic leukemia (ALL), and in treatment for nephroblastoma. It is also used to induce remission in ALL with dexamethasone and L-Asparaginase, and in combination with prednisone to treat childhood leukemia Vincristine is occasionally used as an immunosuppressant, for example, in treating thrombotic thrombocytopenic purpura (TTP) or chronic idiopathic thrombocytopenic purpura (ITP)</p>\n<p><strong>Table:</strong></p><p>Vinblastine & Vincristine Clinical Use Vincristine: Mopp & Cop; Acute Leukemias,\nLymphomas, Wilm's Tumor, Choriocarcinoma Vinblastine: Abvd;, Other Lymphomas, Neuroblastoma,\nTesticular Cancer, Kaposi's Sarcoma Vinorelbine: Advance Non-Small Cell Cancer Adverse Effects: Vinblastine: Git Distress, Alopecia, Bone Marrow\nSuppression Vincristine: Neurotoxicity, Areflexia, Peripheral\nNeuritis, Paralytic Ileus</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0262d1a2",
      "audio": ""
    },
    {
      "text": "Which of the following monoclonal antibody is a humanized antibody directed against VEGF-A?",
      "options": [
        {
          "label": "A",
          "text": "Rituximab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bevacizumab",
          "correct": true
        },
        {
          "label": "C",
          "text": "Trastuzumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Certolizumab",
          "correct": false
        }
      ],
      "correct_answer": "B. Bevacizumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Bevacizumab bevacizumab is a humanized antibody directed against VEGF-A and was the first FDA-approved molecule that specifically targeted angiogenesis.</p>\n<p><strong>Highyeild:</strong></p><p>Bevacizumab a humanized antibody directed against VEGF-A was the first FDA-approved molecule that specifically targeted angiogenesis. As a single agent, it delays the progression of renal-cell cancer in combination with cytotoxic chemotherapy, effectively treats lung, colorectal, and breast cancers Adverse effects are\u2014a rise in BP, arterial thromboembolism leading to heart attack and stroke, vessel injury, nose bleeds, rectal bleeding and other hemorrhages, heart failure, proteinuria, gastrointestinal perforations, and healing defects.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Rituximab against \u2013CD20 Trastuzumab\u2013 AGAINST HER2/neu Certolizumab\u2013 aginst TNF alpha</p>\n<p><strong>Extraedge:</strong></p><p>Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).  VEGF-A is a growth factor protein that stimulates angiogenesis in a variety of diseases, especially in cancer. By binding VEGF-A, bevacizumab should act outside the cell, but in some cases (cervical and breast cancer) it is taken up by cells through constitutive endocytosis. Bevacizumab is the first available angiogenesis inhibitor.</p>\n<p><strong>Table:</strong></p><p>Bevacizumab\n     has recently been used by ophthalmologists in an off-label use as an\n     intravitreal agent in the treatment of proliferative (neovascular) eye\n     diseases, particularly for choroidal neovascular membrane (CNV) in AMD.\n     Although not currently approved by the FDA for such use, the injection of\n     1.25-2.5 mg of bevacizumab into the vitreous cavity has been performed\n     without significant intraocular toxicity. Many retina\n     specialists have noted impressive results in the setting of CNV,\n     proliferative diabetic retinopathy, neovascular glaucoma, diabetic macular\n     edema, retinopathy of prematurity and macular edema secondary to retinal\n     vein occlusions.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2d517d1",
      "audio": ""
    },
    {
      "text": "Which of the following is not a proteasome inhibitor?",
      "options": [
        {
          "label": "A",
          "text": "Bortezomib",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carfilzomib",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ezetimibe",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ixazomib",
          "correct": false
        }
      ],
      "correct_answer": "C. Ezetimibe",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Ezetimibe Ezetimibe, is a medicine used to treat high cholesterol. This medicine helps by reducing \"bad\" cholesterol (LDL). Lowering cholesterol levels reduces the risk of heart attack and stroke. This medicine should be taken with food. Ezetimibe intestinal cholesterol absorption inhibitor used in hyperlipidemia in combination with statins</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- proteasome inhibitor: Bortezomib carfilzomib ixazomib Bortezomib inhibits proteasome resulting in down-regulation of NF- \u03baB used in the treatment of resistant multiple myeloma.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "891e319b",
      "audio": ""
    },
    {
      "text": "Which of the following is a radioprotector?",
      "options": [
        {
          "label": "A",
          "text": "Amifostine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hydroxyurea",
          "correct": false
        },
        {
          "label": "C",
          "text": "5FU",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bromodeoxyuridine",
          "correct": false
        }
      ],
      "correct_answer": "A. Amifostine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Amifostine Amifostine is a phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia . Amifostine anhydrous is a Cytoprotective Agent. The mechanism of action of amifostine anhydrous is a Free Radical Scavenging Activity.</p>\n<p><strong>Highyeild:</strong></p><p>Radioprotectors are chemical compounds that protect the nontumor (normal) cells from radiation during radiotherapy Amifostine is the only clinically approved drug as a radioprotector Amifostine It is an organic thiophosphate which on activation by alkaline phosphatase acts as a cytoprotective against cancer chemotherapy and radiotherapy. Amifostine is particularly used for prophylaxis of cisplatin-induced neuro/nephrotoxicity, and radiotherapy-related xerostomia</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. Hydroxyurea is used in the treatment of some kinds of cancer and to prevent painful episodes associated with sickle cell anemia. It may be also used to treat some other conditions. It is sometimes used with certain other medicines as part of combination chemotherapy. Option: C. 5FU is a cytotoxic chemotherapy medication used to treat cancer. Intravenous injection is used for the treatment of colorectal cancer, oesophageal cancer, stomach cancer, pancreatic cancer, breast cancer, and cervical cancer. Option: D. BrdU is commonly used to study cell proliferation in living tissues and has been studied as a radiosensitizer and diagnostic tool in people with cancer .</p>\n<p><strong>Extraedge:</strong></p><p>Amifostine is used to help lessen the side effects of certain cancer chemotherapy medications or radiation treatment. Amifostine is used to protect the kidneys from harmful effects caused by cisplatin when given to patients with ovarian cancer.</p>\n<p><strong>Table:</strong></p><p>Radioprotectors-Mechanism\nof Action SH compounds\n     effective against sparsely ionizing radiation. Mechanism: Free\n      radical scavenging- 02 based free radical generation or chemotherapy\n      agents H2 atom\n      donation to facilitate direct chemical repair at sites of DNA damage Protective\n     effect of SH compounds tends to parallel 02 the effect, being maximal for\n     sparsely ionizing (x and gamma rays) and minimal for densely ionizing\n     radiation.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d9e78b17",
      "audio": ""
    },
    {
      "text": "Among the following options, the Mechanism of action of Temsirolimus is?",
      "options": [
        {
          "label": "A",
          "text": "mTOR inhibitor",
          "correct": true
        },
        {
          "label": "B",
          "text": "Proteosome inhibitor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Histone deacetylase inhibitors",
          "correct": false
        },
        {
          "label": "D",
          "text": "Protein tyrosine kinase inhibitor",
          "correct": false
        }
      ],
      "correct_answer": "A. mTOR inhibitor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>mTOR inhibitor mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase ( PI3K ) related kinases ( PIKK s). mTOR regulates cellular metabolism, growth, and proliferation.</p>\n<p><strong>Highyeild:</strong></p><p>m TOR inhibitor: Temsirolimus, everolimus histone deacetylase inhibitors: Vorinostat, Romidepsin protein tyrosine kinase inhibitor: Imatinib, dasatinib, sorafenib Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in mammalian cells Temsirolimus This ester analog of sirolimus is converted in the body to sirolimus and acts as an mTOR inhibitor. It is metabolized by CYP3A4 with a t\u00bd of 30 hrs, while its major active metabolite sirolimus has a t\u00bd of 60 hours. Temsirolimus is approved for use in advanced renal cell carcinoma and in refractory mantle cell lymphoma. Dose: 25 mg i.v. weekly</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B . Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. They are being studied in the treatment of cancer, and three are approved for use in treating multiple myeloma Option: C. A class of enzymes that remove acetyl groups (O=C-CH3) from an \u03b5-N-acetyl lysine amino acid on both histone and non-histone proteins . HDACs allow histones to wrap the DNA more tightly. This is important because DNA is wrapped around histones. Option: D. TKIs are typically used as anticancer drug For example, they have substantially improved outcomes in chronic myelogenous leukemi a. They have also been used to treat other diseases, such as idiopathic pulmonary fibrosis.</p>\n<p><strong>Extraedge:</strong></p><p>Mechanism of Action Mtor inhibitors (sirolimus, everolimus) resembles to Tacrolimus but binds to same intracellular FK binding proteins. However, whereas Tacrolimus and cyclosporine block IL-2 gene transcription, sirolimus acts later to block IL-2 dependent lymphocyte proliferation. This blockade is likely due to inhibition of mammalian kinase, an enzyme which is essential for cell cycle progression. Therefore the drug inhibits substantially T and B cell proliferation</p>\n<p><strong>Table:</strong></p><p>mTOR\n     inhibitors Sirolimus,\n      Everolimus, Temsirolimus, Ridaforolimus mTOR\n      kinase inhibitors Immunosuppressive\n     and antiproliferative properties Clinical\n     use Immunosuppressant Prevent\n       kidney/heart rejection Coronary\n      stent coating Cypher,\n       Xience\u00ae Anticancer\n      agent Renal-cell\n      carcinoma (RCC) Mantle-cell\nlymphoma (MCL)</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9bba5223",
      "audio": ""
    }
  ]
}